0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pemetrexed Injection Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-0C12057
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pemetrexed Injection Market Research Report 2022
BUY CHAPTERS

Global Pemetrexed Injection Market Research Report 2025

Code: QYRE-Auto-0C12057
Report
February 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pemetrexed Injection Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pemetrexed Injection Market

Pemetrexed Injection Market

The global market for Pemetrexed Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pemetrexed is an antifolate agent with pyrrolidine pyrimidine group at its core. It can inhibit the growth of tumor by disrupting the normal folate dependent metabolic process in cells and inhibiting cell replication.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pemetrexed Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pemetrexed Injection.
The Pemetrexed Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pemetrexed Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pemetrexed Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pemetrexed Injection Market Report

Report Metric Details
Report Name Pemetrexed Injection Market
CAGR 5%
Segment by Type
  • 0.5g Bottle
  • 0.2g Bottle
Segment by Application
  • Non Squamous Non-Small Cell Lung Cancer
  • Squamous Cell Non-Small Cell Lung Cancer
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eagle Pharmaceuticals, AuroMedics Pharma, Teva Pharmaceutical Industries, Taro Pharma, Seacross Pharmaceuticals, Simcere Pharmaceutical Group, Qilu Pharmaceutical, Pfizer, Jiangsu Anda Pharmaceutical, Yangtze River Pharmaceutical Group, Hansoh Pharmaceutical Group Company, Nanjing Pharmaceutical Factory, DEYAO PHARMA, Vianex S.A.-Plant C, Hainan Jinrui Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pemetrexed Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pemetrexed Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pemetrexed Injection Market report?

Ans: The main players in the Pemetrexed Injection Market are Eagle Pharmaceuticals, AuroMedics Pharma, Teva Pharmaceutical Industries, Taro Pharma, Seacross Pharmaceuticals, Simcere Pharmaceutical Group, Qilu Pharmaceutical, Pfizer, Jiangsu Anda Pharmaceutical, Yangtze River Pharmaceutical Group, Hansoh Pharmaceutical Group Company, Nanjing Pharmaceutical Factory, DEYAO PHARMA, Vianex S.A.-Plant C, Hainan Jinrui Pharmaceutical

What are the Application segmentation covered in the Pemetrexed Injection Market report?

Ans: The Applications covered in the Pemetrexed Injection Market report are Non Squamous Non-Small Cell Lung Cancer, Squamous Cell Non-Small Cell Lung Cancer

What are the Type segmentation covered in the Pemetrexed Injection Market report?

Ans: The Types covered in the Pemetrexed Injection Market report are 0.5g Bottle, 0.2g Bottle

1 Pemetrexed Injection Market Overview
1.1 Product Definition
1.2 Pemetrexed Injection by Type
1.2.1 Global Pemetrexed Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5g Bottle
1.2.3 0.2g Bottle
1.3 Pemetrexed Injection by Application
1.3.1 Global Pemetrexed Injection Market Value by Application (2024 VS 2031)
1.3.2 Non Squamous Non-Small Cell Lung Cancer
1.3.3 Squamous Cell Non-Small Cell Lung Cancer
1.4 Global Pemetrexed Injection Market Size Estimates and Forecasts
1.4.1 Global Pemetrexed Injection Revenue 2020-2031
1.4.2 Global Pemetrexed Injection Sales 2020-2031
1.4.3 Global Pemetrexed Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pemetrexed Injection Market Competition by Manufacturers
2.1 Global Pemetrexed Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pemetrexed Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pemetrexed Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pemetrexed Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pemetrexed Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pemetrexed Injection, Product Type & Application
2.7 Global Key Manufacturers of Pemetrexed Injection, Date of Enter into This Industry
2.8 Global Pemetrexed Injection Market Competitive Situation and Trends
2.8.1 Global Pemetrexed Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pemetrexed Injection Players Market Share by Revenue
2.8.3 Global Pemetrexed Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pemetrexed Injection Market Scenario by Region
3.1 Global Pemetrexed Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pemetrexed Injection Sales by Region: 2020-2031
3.2.1 Global Pemetrexed Injection Sales by Region: 2020-2025
3.2.2 Global Pemetrexed Injection Sales by Region: 2026-2031
3.3 Global Pemetrexed Injection Revenue by Region: 2020-2031
3.3.1 Global Pemetrexed Injection Revenue by Region: 2020-2025
3.3.2 Global Pemetrexed Injection Revenue by Region: 2026-2031
3.4 North America Pemetrexed Injection Market Facts & Figures by Country
3.4.1 North America Pemetrexed Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pemetrexed Injection Sales by Country (2020-2031)
3.4.3 North America Pemetrexed Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pemetrexed Injection Market Facts & Figures by Country
3.5.1 Europe Pemetrexed Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pemetrexed Injection Sales by Country (2020-2031)
3.5.3 Europe Pemetrexed Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pemetrexed Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Pemetrexed Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pemetrexed Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Pemetrexed Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pemetrexed Injection Market Facts & Figures by Country
3.7.1 Latin America Pemetrexed Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pemetrexed Injection Sales by Country (2020-2031)
3.7.3 Latin America Pemetrexed Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pemetrexed Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Pemetrexed Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pemetrexed Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pemetrexed Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pemetrexed Injection Sales by Type (2020-2031)
4.1.1 Global Pemetrexed Injection Sales by Type (2020-2025)
4.1.2 Global Pemetrexed Injection Sales by Type (2026-2031)
4.1.3 Global Pemetrexed Injection Sales Market Share by Type (2020-2031)
4.2 Global Pemetrexed Injection Revenue by Type (2020-2031)
4.2.1 Global Pemetrexed Injection Revenue by Type (2020-2025)
4.2.2 Global Pemetrexed Injection Revenue by Type (2026-2031)
4.2.3 Global Pemetrexed Injection Revenue Market Share by Type (2020-2031)
4.3 Global Pemetrexed Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pemetrexed Injection Sales by Application (2020-2031)
5.1.1 Global Pemetrexed Injection Sales by Application (2020-2025)
5.1.2 Global Pemetrexed Injection Sales by Application (2026-2031)
5.1.3 Global Pemetrexed Injection Sales Market Share by Application (2020-2031)
5.2 Global Pemetrexed Injection Revenue by Application (2020-2031)
5.2.1 Global Pemetrexed Injection Revenue by Application (2020-2025)
5.2.2 Global Pemetrexed Injection Revenue by Application (2026-2031)
5.2.3 Global Pemetrexed Injection Revenue Market Share by Application (2020-2031)
5.3 Global Pemetrexed Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eagle Pharmaceuticals
6.1.1 Eagle Pharmaceuticals Company Information
6.1.2 Eagle Pharmaceuticals Description and Business Overview
6.1.3 Eagle Pharmaceuticals Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eagle Pharmaceuticals Pemetrexed Injection Product Portfolio
6.1.5 Eagle Pharmaceuticals Recent Developments/Updates
6.2 AuroMedics Pharma
6.2.1 AuroMedics Pharma Company Information
6.2.2 AuroMedics Pharma Description and Business Overview
6.2.3 AuroMedics Pharma Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AuroMedics Pharma Pemetrexed Injection Product Portfolio
6.2.5 AuroMedics Pharma Recent Developments/Updates
6.3 Teva Pharmaceutical Industries
6.3.1 Teva Pharmaceutical Industries Company Information
6.3.2 Teva Pharmaceutical Industries Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Pharmaceutical Industries Pemetrexed Injection Product Portfolio
6.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.4 Taro Pharma
6.4.1 Taro Pharma Company Information
6.4.2 Taro Pharma Description and Business Overview
6.4.3 Taro Pharma Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Taro Pharma Pemetrexed Injection Product Portfolio
6.4.5 Taro Pharma Recent Developments/Updates
6.5 Seacross Pharmaceuticals
6.5.1 Seacross Pharmaceuticals Company Information
6.5.2 Seacross Pharmaceuticals Description and Business Overview
6.5.3 Seacross Pharmaceuticals Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Seacross Pharmaceuticals Pemetrexed Injection Product Portfolio
6.5.5 Seacross Pharmaceuticals Recent Developments/Updates
6.6 Simcere Pharmaceutical Group
6.6.1 Simcere Pharmaceutical Group Company Information
6.6.2 Simcere Pharmaceutical Group Description and Business Overview
6.6.3 Simcere Pharmaceutical Group Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Simcere Pharmaceutical Group Pemetrexed Injection Product Portfolio
6.6.5 Simcere Pharmaceutical Group Recent Developments/Updates
6.7 Qilu Pharmaceutical
6.7.1 Qilu Pharmaceutical Company Information
6.7.2 Qilu Pharmaceutical Description and Business Overview
6.7.3 Qilu Pharmaceutical Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Qilu Pharmaceutical Pemetrexed Injection Product Portfolio
6.7.5 Qilu Pharmaceutical Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Pemetrexed Injection Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Jiangsu Anda Pharmaceutical
6.9.1 Jiangsu Anda Pharmaceutical Company Information
6.9.2 Jiangsu Anda Pharmaceutical Description and Business Overview
6.9.3 Jiangsu Anda Pharmaceutical Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Portfolio
6.9.5 Jiangsu Anda Pharmaceutical Recent Developments/Updates
6.10 Yangtze River Pharmaceutical Group
6.10.1 Yangtze River Pharmaceutical Group Company Information
6.10.2 Yangtze River Pharmaceutical Group Description and Business Overview
6.10.3 Yangtze River Pharmaceutical Group Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Yangtze River Pharmaceutical Group Pemetrexed Injection Product Portfolio
6.10.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
6.11 Hansoh Pharmaceutical Group Company
6.11.1 Hansoh Pharmaceutical Group Company Company Information
6.11.2 Hansoh Pharmaceutical Group Company Description and Business Overview
6.11.3 Hansoh Pharmaceutical Group Company Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hansoh Pharmaceutical Group Company Pemetrexed Injection Product Portfolio
6.11.5 Hansoh Pharmaceutical Group Company Recent Developments/Updates
6.12 Nanjing Pharmaceutical Factory
6.12.1 Nanjing Pharmaceutical Factory Company Information
6.12.2 Nanjing Pharmaceutical Factory Description and Business Overview
6.12.3 Nanjing Pharmaceutical Factory Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Nanjing Pharmaceutical Factory Pemetrexed Injection Product Portfolio
6.12.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
6.13 DEYAO PHARMA
6.13.1 DEYAO PHARMA Company Information
6.13.2 DEYAO PHARMA Description and Business Overview
6.13.3 DEYAO PHARMA Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 DEYAO PHARMA Pemetrexed Injection Product Portfolio
6.13.5 DEYAO PHARMA Recent Developments/Updates
6.14 Vianex S.A.-Plant C
6.14.1 Vianex S.A.-Plant C Company Information
6.14.2 Vianex S.A.-Plant C Description and Business Overview
6.14.3 Vianex S.A.-Plant C Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Vianex S.A.-Plant C Pemetrexed Injection Product Portfolio
6.14.5 Vianex S.A.-Plant C Recent Developments/Updates
6.15 Hainan Jinrui Pharmaceutical
6.15.1 Hainan Jinrui Pharmaceutical Company Information
6.15.2 Hainan Jinrui Pharmaceutical Description and Business Overview
6.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Portfolio
6.15.5 Hainan Jinrui Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pemetrexed Injection Industry Chain Analysis
7.2 Pemetrexed Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pemetrexed Injection Production Mode & Process Analysis
7.4 Pemetrexed Injection Sales and Marketing
7.4.1 Pemetrexed Injection Sales Channels
7.4.2 Pemetrexed Injection Distributors
7.5 Pemetrexed Injection Customer Analysis
8 Pemetrexed Injection Market Dynamics
8.1 Pemetrexed Injection Industry Trends
8.2 Pemetrexed Injection Market Drivers
8.3 Pemetrexed Injection Market Challenges
8.4 Pemetrexed Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pemetrexed Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pemetrexed Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pemetrexed Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pemetrexed Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pemetrexed Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pemetrexed Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pemetrexed Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pemetrexed Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pemetrexed Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pemetrexed Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pemetrexed Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Pemetrexed Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pemetrexed Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pemetrexed Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pemetrexed Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pemetrexed Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Pemetrexed Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pemetrexed Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Pemetrexed Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pemetrexed Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Pemetrexed Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pemetrexed Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Pemetrexed Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pemetrexed Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pemetrexed Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pemetrexed Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pemetrexed Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pemetrexed Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pemetrexed Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pemetrexed Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pemetrexed Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pemetrexed Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pemetrexed Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pemetrexed Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pemetrexed Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pemetrexed Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pemetrexed Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pemetrexed Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pemetrexed Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pemetrexed Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pemetrexed Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pemetrexed Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pemetrexed Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pemetrexed Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pemetrexed Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pemetrexed Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pemetrexed Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pemetrexed Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Pemetrexed Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Pemetrexed Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Pemetrexed Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Pemetrexed Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pemetrexed Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pemetrexed Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Pemetrexed Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Pemetrexed Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pemetrexed Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pemetrexed Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Pemetrexed Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Pemetrexed Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Pemetrexed Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Pemetrexed Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pemetrexed Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pemetrexed Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Pemetrexed Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Pemetrexed Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pemetrexed Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Eagle Pharmaceuticals Company Information
 Table 71. Eagle Pharmaceuticals Description and Business Overview
 Table 72. Eagle Pharmaceuticals Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Eagle Pharmaceuticals Pemetrexed Injection Product
 Table 74. Eagle Pharmaceuticals Recent Developments/Updates
 Table 75. AuroMedics Pharma Company Information
 Table 76. AuroMedics Pharma Description and Business Overview
 Table 77. AuroMedics Pharma Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AuroMedics Pharma Pemetrexed Injection Product
 Table 79. AuroMedics Pharma Recent Developments/Updates
 Table 80. Teva Pharmaceutical Industries Company Information
 Table 81. Teva Pharmaceutical Industries Description and Business Overview
 Table 82. Teva Pharmaceutical Industries Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teva Pharmaceutical Industries Pemetrexed Injection Product
 Table 84. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 85. Taro Pharma Company Information
 Table 86. Taro Pharma Description and Business Overview
 Table 87. Taro Pharma Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Taro Pharma Pemetrexed Injection Product
 Table 89. Taro Pharma Recent Developments/Updates
 Table 90. Seacross Pharmaceuticals Company Information
 Table 91. Seacross Pharmaceuticals Description and Business Overview
 Table 92. Seacross Pharmaceuticals Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Seacross Pharmaceuticals Pemetrexed Injection Product
 Table 94. Seacross Pharmaceuticals Recent Developments/Updates
 Table 95. Simcere Pharmaceutical Group Company Information
 Table 96. Simcere Pharmaceutical Group Description and Business Overview
 Table 97. Simcere Pharmaceutical Group Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Simcere Pharmaceutical Group Pemetrexed Injection Product
 Table 99. Simcere Pharmaceutical Group Recent Developments/Updates
 Table 100. Qilu Pharmaceutical Company Information
 Table 101. Qilu Pharmaceutical Description and Business Overview
 Table 102. Qilu Pharmaceutical Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Qilu Pharmaceutical Pemetrexed Injection Product
 Table 104. Qilu Pharmaceutical Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Pfizer Pemetrexed Injection Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. Jiangsu Anda Pharmaceutical Company Information
 Table 111. Jiangsu Anda Pharmaceutical Description and Business Overview
 Table 112. Jiangsu Anda Pharmaceutical Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Jiangsu Anda Pharmaceutical Pemetrexed Injection Product
 Table 114. Jiangsu Anda Pharmaceutical Recent Developments/Updates
 Table 115. Yangtze River Pharmaceutical Group Company Information
 Table 116. Yangtze River Pharmaceutical Group Description and Business Overview
 Table 117. Yangtze River Pharmaceutical Group Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Yangtze River Pharmaceutical Group Pemetrexed Injection Product
 Table 119. Yangtze River Pharmaceutical Group Recent Developments/Updates
 Table 120. Hansoh Pharmaceutical Group Company Company Information
 Table 121. Hansoh Pharmaceutical Group Company Description and Business Overview
 Table 122. Hansoh Pharmaceutical Group Company Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hansoh Pharmaceutical Group Company Pemetrexed Injection Product
 Table 124. Hansoh Pharmaceutical Group Company Recent Developments/Updates
 Table 125. Nanjing Pharmaceutical Factory Company Information
 Table 126. Nanjing Pharmaceutical Factory Description and Business Overview
 Table 127. Nanjing Pharmaceutical Factory Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Nanjing Pharmaceutical Factory Pemetrexed Injection Product
 Table 129. Nanjing Pharmaceutical Factory Recent Developments/Updates
 Table 130. DEYAO PHARMA Company Information
 Table 131. DEYAO PHARMA Description and Business Overview
 Table 132. DEYAO PHARMA Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. DEYAO PHARMA Pemetrexed Injection Product
 Table 134. DEYAO PHARMA Recent Developments/Updates
 Table 135. Vianex S.A.-Plant C Company Information
 Table 136. Vianex S.A.-Plant C Description and Business Overview
 Table 137. Vianex S.A.-Plant C Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Vianex S.A.-Plant C Pemetrexed Injection Product
 Table 139. Vianex S.A.-Plant C Recent Developments/Updates
 Table 140. Hainan Jinrui Pharmaceutical Company Information
 Table 141. Hainan Jinrui Pharmaceutical Description and Business Overview
 Table 142. Hainan Jinrui Pharmaceutical Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hainan Jinrui Pharmaceutical Pemetrexed Injection Product
 Table 144. Hainan Jinrui Pharmaceutical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Pemetrexed Injection Distributors List
 Table 148. Pemetrexed Injection Customers List
 Table 149. Pemetrexed Injection Market Trends
 Table 150. Pemetrexed Injection Market Drivers
 Table 151. Pemetrexed Injection Market Challenges
 Table 152. Pemetrexed Injection Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pemetrexed Injection
 Figure 2. Global Pemetrexed Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pemetrexed Injection Market Share by Type: 2024 & 2031
 Figure 4. 0.5g Bottle Product Picture
 Figure 5. 0.2g Bottle Product Picture
 Figure 6. Global Pemetrexed Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pemetrexed Injection Market Share by Application: 2024 & 2031
 Figure 8. Non Squamous Non-Small Cell Lung Cancer
 Figure 9. Squamous Cell Non-Small Cell Lung Cancer
 Figure 10. Global Pemetrexed Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pemetrexed Injection Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pemetrexed Injection Sales (2020-2031) & (K Units)
 Figure 13. Global Pemetrexed Injection Average Price (US$/Unit) & (2020-2031)
 Figure 14. Pemetrexed Injection Report Years Considered
 Figure 15. Pemetrexed Injection Sales Share by Manufacturers in 2024
 Figure 16. Global Pemetrexed Injection Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pemetrexed Injection Players: Market Share by Revenue in Pemetrexed Injection in 2024
 Figure 18. Pemetrexed Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pemetrexed Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pemetrexed Injection Sales Market Share by Country (2020-2031)
 Figure 21. North America Pemetrexed Injection Revenue Market Share by Country (2020-2031)
 Figure 22. United States Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Pemetrexed Injection Sales Market Share by Country (2020-2031)
 Figure 25. Europe Pemetrexed Injection Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pemetrexed Injection Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Pemetrexed Injection Revenue Market Share by Region (2020-2031)
 Figure 33. China Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Pemetrexed Injection Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Pemetrexed Injection Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Pemetrexed Injection Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Pemetrexed Injection Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Pemetrexed Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Pemetrexed Injection by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Pemetrexed Injection by Type (2020-2031)
 Figure 54. Global Pemetrexed Injection Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Pemetrexed Injection by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Pemetrexed Injection by Application (2020-2031)
 Figure 57. Global Pemetrexed Injection Price (US$/Unit) by Application (2020-2031)
 Figure 58. Pemetrexed Injection Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmaceutical Labelling Machine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13D10320
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Strip Packaging Machines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36X10626
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Joint Reinforcement Paste Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29I10537
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Coating Devcie Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7E13021
Thu Feb 20 00:00:00 UTC 2025

Add to Cart